Sandro Pasquali (@sandro_pasquali) 's Twitter Profile
Sandro Pasquali

@sandro_pasquali

Clinician scientist at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.

ID: 1278798654

calendar_today18-03-2013 21:38:43

2,2K Tweet

667 Followers

641 Following

Sarcoma Foundation of America (@curesarcoma) 's Twitter Profile Photo

We're at #CTOS2024 sharing our poster on the patient experience with liposarcoma! Our poster "Patient Perspective on Liposarcoma Diagnostic Journey: Interim Patient Survey Results" (p206) reveals key insights into diagnosis, treatment, and the need for greater awareness and

We're at #CTOS2024 sharing our poster on the patient experience with liposarcoma! 

Our poster "Patient Perspective on Liposarcoma Diagnostic Journey: Interim Patient Survey Results" (p206) reveals key insights into diagnosis, treatment, and the need for greater awareness and
Andrea Franza, MD (@andrea_franza) 's Twitter Profile Photo

Postcards from #CTOS2024 day2: opening ceremony, a great presentation by Stefano Radaelli for SACRO study and some good talks at poster reception at the end of the day. CTOS

Postcards from #CTOS2024 day2: opening ceremony, a great presentation by <a href="/radaste/">Stefano Radaelli</a> for SACRO study and some good talks at poster reception at the end of the day.

<a href="/ctosociety/">CTOS</a>
Pawel Sobczuk (@pawel_sobczuk) 's Twitter Profile Photo

Very interesting data from TARPSWG about concordance of histology and grade accuracy between biopsy and surgical material 🔸higher accuracy in big centers and US/CT-guided biopsy 🔸grade frequently underestimated (~27%) #CTOS2024 CTOS

Very interesting data from <a href="/TARPSWG/">TARPSWG</a> about concordance of histology and grade accuracy between biopsy and surgical material
🔸higher accuracy in big centers and US/CT-guided biopsy
🔸grade frequently underestimated (~27%)
#CTOS2024 <a href="/ctosociety/">CTOS</a>
Alessandro Gronchi (@alegronchi) 's Twitter Profile Photo

¼ Great #retroperitoneal #sarcoma session at CTOS today. Lots of data coming from international collaboration to understand the possible prognostication improvement by using genomic signatures, the application of benchmark for RPS surgery for proper comparisons...

¼ Great #retroperitoneal #sarcoma session at <a href="/ctosociety/">CTOS</a> today. Lots of data coming from international collaboration to understand the possible prognostication improvement by using genomic signatures, the application of benchmark for RPS surgery for proper comparisons...
Alessandro Gronchi (@alegronchi) 's Twitter Profile Photo

2/4 the implication of histologic organ infiltration for surgical strategy and risk of recurrence, the natural history of PEComa, the outcome over time of a very large series of RPS patients treated at a single Institution with implications for the management of the RPS types

2/4 the implication of histologic organ infiltration for surgical strategy and risk of recurrence, the natural history of PEComa, the outcome over time of a very large series of RPS patients treated at a single Institution with implications for the management of the RPS types
R. Lor Randall (@rlrandallmd) 's Twitter Profile Photo

Kudos to Robert Maki,MD,past President of ctos, an extraordinary person & med onc for giving the annual Nina Axelrad Lecture. Bob is a truly kind,humble,brilliant clinician-scientist. He has been a beacon for me throughout my career. “What would Bob do?” Congrats! UC Davis Department of Orthopaedic Surgery

Kudos to Robert Maki,MD,past President of <a href="/ctos/">ctos</a>, an extraordinary person &amp; med onc for giving the annual Nina Axelrad Lecture. Bob is a truly kind,humble,brilliant clinician-scientist. He has been a beacon for me throughout my career. “What would Bob do?” Congrats! <a href="/UCDavisOrtho/">UC Davis Department of Orthopaedic Surgery</a>
Alessandro Gronchi (@alegronchi) 's Twitter Profile Photo

Daniela Salvatore presenting at the CTOS annual meeting in San Diego the #RESAR platform and framework agreement, which has enabled clinical data sharing about primary #retroperitoneal #sarcoma between multiple insitutions worldwide. Great job Dani! We are so proud of you!

<a href="/Dan_Salvatore/">Daniela Salvatore</a> presenting at the <a href="/ctosociety/">CTOS</a> annual meeting in San Diego the #RESAR platform and framework agreement, which has enabled clinical data sharing about primary #retroperitoneal #sarcoma between multiple insitutions worldwide. Great job Dani! We are so proud of you!
Alessandro Gronchi (@alegronchi) 's Twitter Profile Photo

Prof. Bruno Vincenzi at CTOS annual meeting presents a post-hoc analysis on high risk progressing desmoid tumor within the DEFI randomized study. Nirogacestat works also in desmoid tumors which are larger, harbor a worse mutational status (s45F) and more. Italian Sarcoma Group

Prof. Bruno Vincenzi at <a href="/ctosociety/">CTOS</a> annual meeting presents a post-hoc analysis on high risk progressing desmoid tumor within the DEFI randomized study. Nirogacestat works also in desmoid tumors which are larger, harbor a worse mutational status (s45F) and more. <a href="/ItaSarcomaGroup/">Italian Sarcoma Group</a>
TGCT Support (@tgctsupportorg) 's Twitter Profile Photo

William Tap shows that Pexidartinib tumor response is unaffected by prior surgeries but Pexidartinib may have higher benefit in pain, worst stiffness, and range of motion in pts w/ no prior surgery compared to those with repeat surgeries. Small numbers but interesting! #CTOS2024

<a href="/WTapMD/">William Tap</a> shows that Pexidartinib tumor response is unaffected by prior surgeries but Pexidartinib may have higher benefit in pain, worst stiffness, and range of motion in pts w/ no prior surgery compared to those with repeat surgeries.  Small numbers but interesting! #CTOS2024
Lorenzo D'Ambrosio (@dambrosio_md) 's Twitter Profile Photo

Great #CTOS 2024 Annual Meeting in San Diego! Always a unique time for ideas exchange and meeting new and old friends from all around the world. Looking forward for future steps in #sarcoma research! #PUSH Alessandra Merlini Silvia Stacchiotti William Tap Tom Wei-Wu Chen Herbert Loong, MBBS, FASCO Alessandro Gronchi

Great #CTOS 2024 Annual Meeting in San Diego!
Always a unique time for ideas exchange and meeting new and old friends from all around the world.
Looking forward for future steps in #sarcoma research!
#PUSH 
<a href="/merlini_ale/">Alessandra Merlini</a> <a href="/SilviaStacchia/">Silvia Stacchiotti</a> <a href="/WTapMD/">William Tap</a> <a href="/saxotomy/">Tom Wei-Wu Chen</a> <a href="/herbloong/">Herbert Loong, MBBS, FASCO</a> <a href="/alegronchi/">Alessandro Gronchi</a>
Andrea Franza, MD (@andrea_franza) 's Twitter Profile Photo

Wrapping up last day of #CTOS2024! Again, so many interesting presentations, a fantastic crew of colleagues/friends and a super sunset to say goodbye to SD. CTOS

Wrapping up last day of #CTOS2024! Again, so many interesting presentations, a  fantastic crew of colleagues/friends and a super sunset to say goodbye to SD.

<a href="/ctosociety/">CTOS</a>
Istituto Tumori (@isttumori) 's Twitter Profile Photo

La vita di 25 giovani pazienti oncologici in una sitcom:quando e dove vederla. Realizzata in collaborazione con Mediafriends e con il supporto della Fondazione Bianca Garavaglia,è stata scritta e recitata dai ragazzi del Progetto Giovani dell' Istituto Tumori ilgiorno.it/magazine/serie…

Istituto Tumori (@isttumori) 's Twitter Profile Photo

🎉 Siamo orgogliosi di annunciare che la Dr.ssa Silvia Stacchiotti ha ricevuto un prestigioso riconoscimento agli Italian Knowledge Leaders per la sua ricerca sui sarcomi! Silvia Stacchiotti Dal 1° gennaio 2025, sarà presidente della CTOS. Scopri di più 👇👇 linkedin.com/feed/update/ur…

🎉 Siamo orgogliosi di annunciare che la Dr.ssa Silvia Stacchiotti ha ricevuto un prestigioso riconoscimento agli Italian Knowledge Leaders per la sua ricerca sui sarcomi! <a href="/SilviaStacchia/">Silvia Stacchiotti</a> 
Dal 1° gennaio 2025, sarà presidente della CTOS. Scopri di più 👇👇
linkedin.com/feed/update/ur…
European Society of Surgical Oncology (ESSO) (@essonews) 's Twitter Profile Photo

🎥 Dr. Marco Fiore Marco Fiore, MD, FACS, FEBSh, Director of the European School of Soft Tissue Sarcoma Surgery (ESSTSS), invites you to join this programme! 🌟 Watch his message here: buff.ly/4fsuTqK #SarcomaSurgery #ESSOEducation

🎥 Dr. Marco Fiore <a href="/FioreDoc/">Marco Fiore, MD, FACS, FEBSh</a>, Director of the European School of Soft Tissue Sarcoma Surgery (ESSTSS), invites you to join this programme! 🌟
Watch his message here: buff.ly/4fsuTqK 
#SarcomaSurgery #ESSOEducation